TickerFacts.

Stemtech Corp (STEK): Long-Term Debt

Annual figures by period end, from SEC filings.

$4.16M
As of 2025-12-31
$4.40M
As of 2026-06-30
+64.8%
3-year compound annual growth
2022-12-31: $929.1K2023-12-31: $3.49M2024-12-31: $3.82M2025-12-31: $4.16M$4.16M
2022-12-31 Long-Term Debt (USD) 2025-12-31
Period endedLong-Term DebtChange YoYSource filing
2025-12-31$4.16M+9.1%2026-05-29, Balance as of period end
2024-12-31$3.82M+9.4%2026-05-29, Balance as of period end
2023-12-31$3.49M+275.2%2025-06-30, Balance as of period end
2022-12-31$929.1Kn/a2024-07-10, Balance as of period end

Long-Term Debt at similar companies

Companies with the same SEC industry code (Wholesale-Drugs, Proprietaries & Druggists' Sundries), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedLong-Term DebtChange YoY
Stemtech Corp (STEK)2025-12-31$4.16M+9.1%
DataMeds AI, Inc. (MEDS)2025-12-31$23.49M+0.4%
Cosmos Health Inc. (COSM)2025-12-31$3.78M-8.1%
Herbalife Ltd. (HLF)2025-12-31$1.99B-11.8%
Cencora, Inc. (COR)2025-09-30$7.66B+74.6%
McKesson Corp (MCK)2026-03-31$6.53B+15.4%

Compare STEK, MEDS, COSM, HLF side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗